The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Gilead Sciences Ireland UCEU/1/09/543/001

Main Information

Trade NameCayston
Active SubstancesAztreonam (as lysine salt)
Dosage FormPowder and solvent for nebuliser solution
Licence HolderGilead Sciences Ireland UC
Licence NumberEU/1/09/543/001

Group Information

ATC CodeJ01DF01 aztreonam


License statusAuthorised
Licence Issued21/09/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back